Home | Contact Us | FAQ | Search & Site Map | Link to Us
Sign In | Join | Other 45 Sites in Network
Home
Discussion Groups
General
GeneralCardiologyVisionDentistryPharmacyLaboratoryNutritionAlternative
Diseases and Disorders
AIDSAlzheimer'sArthritisAsthmaCancerBreast CancerDiabetesEpilepsyGlaucomaHepatitisHerpesLupusProstate BPHProstate CancerProstatitisSinusitisTinnitus

Medical Forum / Diseases and Disorders / Lupus / November 2007

Tip: Looking for answers? Try searching our database.

ThreadLast Post  Replies
Mycophenolate Mofetil Reduces Erythropoiesis10 Nov 2007 20:01 GMT2
This drug is used to reduce red blood cell production .. and it works
in lupus .. surprise .. surprise.
Would kind of make one wonder whether increased red blood cell
production and connective tissue disease are .. linked.
Iron-chelators and Antioxidants and Myelodysplastic Syndrome08 Nov 2007 16:01 GMT7
"Patients might benefit from treatment with iron-chelators and
antioxidants"
Eur J Haematol. 2007 Nov 1; [Epub ahead of print]
Oxidative stress in red blood cells, platelets and polymorphonuclear
Joint Lubrication08 Nov 2007 14:51 GMT3
If the ingestion of different fatty acids changes the fatty acids in
the mammals body would the ingestion and / or liberal application of
topical lecithin BE an effective alternative to these injections.. ?
Lecithin bathes the joints / lubricant.
Myelodysplastic Syndrome and Iron05 Nov 2007 14:33 GMT1
A little data mining would have saved these guys some time .. this was
hypothesized and proven quite awhile ago.
<<snip>>
high incidence rate of HFE gene mutations among MDS patients
Shelagh ? Canadian Resources05 Nov 2007 09:38 GMT6
Shelagh ?
Got these? (for your webpage or list of resources.
http://www.bclupus.org/
http://www.lupuscanada.org/pei/
Pages: 1 2 October, 2007
 
Sign In
Join
My Latest Posts
My Monitored Threads
My Blog
My Photo Gallery
My Profile
My Homepage

Start New Thread



©2008 Advenet LLC   Privacy Policy - Terms of Use
This website includes both content owned or controlled by Advenet as well as content owned or controlled by third parties.